RIVZEPRI Trademark

Trademark Overview

On Friday, February 18, 2022, a trademark application was filed for RIVZEPRI with the United States Patent and Trademark Office. The USPTO has given the RIVZEPRI trademark a serial number of 97274856. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, October 7, 2025. This trademark is owned by FibroGen, Inc.. The RIVZEPRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis
rivzepri

General Information

Serial Number97274856
Word MarkRIVZEPRI
Filing DateFriday, February 18, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, October 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFibroGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94133
US
Party NameFibroGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158
US

Trademark Events

Event DateEvent Description
Tuesday, February 22, 2022NEW APPLICATION ENTERED
Thursday, February 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 15, 2022ASSIGNED TO EXAMINER
Wednesday, August 17, 2022SUSPENSION LETTER WRITTEN
Wednesday, August 17, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, August 17, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 21, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 23, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 18, 2024SOU EXTENSION 1 FILED
Tuesday, June 18, 2024SOU EXTENSION 1 GRANTED
Tuesday, June 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 7, 2025ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 7, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

rivzepri pharmaceutical treatment preparations dystrophy idiopathic fibrosis muscular pulmonary disorders chronic